forensic chem 2

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/159

encourage image

There's no tags or description

Looks like no tags are added yet.

160 Terms

1
New cards

Homicidal poisoning

the killing of a human being by the administration of poison

2
New cards

fulminant poisoning

Owing to the massive dose, death precedes very rapidly without any onset of symptoms

3
New cards

Toxic Syndrome

  • Cholinergic Syndrome

  • Anticholinergic Syndrome

  • Sympathomimetic Syndrome

  • Sedative/Hypnotic Syndrome


4
New cards

On the basis of duration of exposure, sign and symptoms, medical practitioner can categorize the poisoning in

fulminate, acute, sub-acute, chronic and sub chronic

5
New cards

Vital Signs

associated with the overdosed cases, cardiac arrhythmias, respiratory/ cardiovascular depression, and impairment of consciousness, convulsions agitation, and muscular weakness

6
New cards

Postmortem redistribution (PMR)

• Drug movements within the body after death.

• This cause time- dependent variations in blood and tissue drug concentrations prior to autopsy

7
New cards

Major contributing elements to PMR

•Drug Chemistry

•Drug Pharmacokinetics

•Distribution Mechanisms

8
New cards

Drug Chemistry

• Acid / Base Properties (pKa)

• Lipophilicity

• Size and Structure

9
New cards

pKa?

It is derived from Ka which is the equilibrium constant for the chemical reaction known as dissociation in the context of acid-base reactions

pKa = - log10Ka


10
New cards

the smaller the pKa the stronger the acid

the higher the pKa, the stronger the base

• Thus one can determine the degree of ionization at a given pH

11
New cards

Normal biological pH

7.4

12
New cards

When we substitute these elements (pH and pKa) in to the Henderson-Hasselbalch equation

we can mathematically determine how much of a drug is ionized at a biological pH

pH = pKa + log([conjugate base]/[conjugate acid])

pOH = pKa + log([conjugate base]/[conjugate acid])

13
New cards

Lipophilicity

the ability of a chemical compound (lipophilic) to dissolve in fats, oils, lipids, and non-polar solvents such as hexane or toluene.

14
New cards

hydrophilic ("water-loving") substances

tend to dissolve in water

15
New cards

The nonionized form of the drug

tends to be more lipid soluble=more lipophilic

16
New cards

Drug Chemistry effects drugs ability to

bind with plasma proteins and tissues in the blood

17
New cards

Volume of Distribution (Vd)

  • pharmacokinetic parameter representing an individual drug’s propensity to either remain in the plasma or redistribute to other tissue compartments.

  • Vd is a proportionality constant that relates the total amount of drug in the body to the plasma concentration of the drug at a given time.

  • meaning that a higher dose of a drug is required to achieve a given plasma concentration


18
New cards

Cell Death


- Aerobic respiration stops

- Oxygen is no longer provided (hypoxia)

- In the mitochondria, oxygen was the final electron receptor of the electron transport system responsible for the synthesis of ATP from NADH

• Thus we no longer have ATP to run cellular operations - and cellular death begins

19
New cards

Build up of lactic acid

result in decreases in intercellular pH

20
New cards

Lysosomal enzymes

leak out and become active

21
New cards

Distribution Mechanism

  • “Micro” Redistribution

  • Acidification

  • Passive Diffusion

  • Blood Coagulation and Hypostasis

  • Postmortem “Circulation”

  • Putrefaction


22
New cards

Micro Redistribution

• Enzymes, proteases, phosphatases, glucosidases all leak into the cytoplasm - further breaking down cellular components

• Macromolecules, proteins, and the drugs bound to them (or detached) drift out into the extracellular space

• This tends to be higher in tissues rich in enzymes (pancreas and gastric mucosa) and slower in the heart, liver, and kidney

23
New cards

Acidification

  • Contents of a cell become more acidified after death

• After a cell lyses, progressively ionized drugs will distribute more readily as a result of being transported in the acidic fluid in which they are dissolved

24
New cards

Redistribution

blood and tissue

25
New cards

Passive Diffusion

  • Organs which are close to the heart and major blood vessels

  • temp and concentration can effect this


26
New cards

Blood Coagulation and Hypostasis (Livor)

• Blood sediments and clots unevenly after death

• This is due to blood clotting and cell lysis happening simultaneously

• As hours pass, hypostasis occurs when the blood sediments and serum flow, according to gravity, to the lower parts of the body

• Drugs follow according to their respective chemistries

27
New cards

Body Position

• It’s been demonstrated that body position may influence PMR

28
New cards

Putrefaction

Decomposition of organic matter by bacterial or fungal digestion, which causes the release of gases that infiltrate the body's tissues and leads to the deterioration of the tissues and organs.

29
New cards

Enteric bacteria

can metabolize drugs and produce ethanol

30
New cards

Postmortem circulation

• Rigor mortis can cause blood movement by causing systolic pressure through ventricular contractions

• Putrefactive processes in the abdomen can move blood due to gas swelling

31
New cards

Environmental Conditions

• Storing decedents between 2 – 8oC prior to autopsy

-Slows redistribution

-Slows putrefaction

• Conversely, warmer temperatures have the opposite effect

32
New cards

Autopsy specimens

• Central Blood (#1 Heart, #2 Subclavian artery)

• Peripheral Blood (#3 Inferior Vena Cava)

• Vitreous Humor

• Tissue (Liver, Brain)

33
New cards

Testing alternative tissues

• Lung

• Cerebrospinal fluid

• Bone Marrow

• Skeletal Muscle

34
New cards

Drug distribution

the disbursement of an unmetabolized drug as it moves through the body’s blood and tissues

  • the brain and testes are unique


35
New cards

lipophilic or hydrophilic

Based on lipid and non-lipid solubility, drugs can be classified as

36
New cards

Lipophiliic (Fat Soluble)

• Biotransformed in the liver

• Excreted through the bile duct

37
New cards

Hydrophilic (Water Soluble)


• Eliminated by kidneys

38
New cards

Pervitin. aka “Piko”

Germany marketed methamphetamine tablets

39
New cards

2010s–Present

While public and regulatory attention shifted toward prescription opioids, illicit methamphetamine trafficking, high-purity crystal meth, and liquid methamphetamine concealment by transnational cartels continued to rise nationwide, accompanied by increasing stimulant-related overdose trends.

40
New cards

Xylazine

a non-opioid veterinary tranquilizer, muscle relaxant, and central nervous system depressant.

41
New cards

drug

a natural or synthetic substance used to produce physiological or psychological effects

42
New cards

Narcotic drugs

(analgesics) relieve pain by depressing the CNS, affecting blood pressure, pulse, and breathing

43
New cards

Opiate

a drug derived from the opium poppy (morphine, codeine); excludes synthetics

44
New cards

Opioid

any substance with morphine-like activity: natural, semi-synthetic, and synthetic (includes fentanyl)

45
New cards

Narcotic

an obsolete, loosely used legal/media term for drugs of abuse; avoid it scientifically

46
New cards

Addiction

Psychological dependence with compulsive use and craving, continuing despite harm.

47
New cards

Tolerance

Higher doses needed over time to produce the same effect.


48
New cards

Dependence

Sudden absence produces a physical withdrawal syndrome.


49
New cards

Withdrawal

Cluster of physiological signs/symptoms after abruptly stopping a drug

50
New cards

Physical addiction

(alcohol, opioids, depressants) causes withdrawal sickness

51
New cards

psychological addiction

(cocaine, PCP) is driven by dopamine reward

52
New cards

schedule i

High abuse; no accepted medical use

Heroin, LSD, MDMA, psilocybin, most marijuana*


53
New cards

schedule ii

High abuse; accepted use, severe dependence

Cocaine, methamphetamine, fentanyl, oxycodone, morphine

54
New cards

schedule iii

Moderate/low dependence; accepted use

Ketamine, buprenorphine, anabolic steroids, medical marijuana*


55
New cards

schedule iv

Low abuse vs III

Diazepam, alprazolam, zolpidem, tramadol

56
New cards

schedule v

Lowest abuse; limited narcotics

Limited-codeine cough preps, pregabalin

57
New cards

In April 2026 the DEA moved FDA-approved and state-licensed medical marijuana to

Schedule III; broader rescheduling was still pending. Schedules are a legal, not pharmacological, classification — verify current status.

58
New cards

Stimulants

Increase alertness and energy

Cocaine, methamphetamine, MDMA

59
New cards

Opioids

Pain relief, sedation, respiratory depression

Heroin, oxycodone, fentanyl

60
New cards

Depressants

Slow CNS activity

Benzodiazepines, barbiturates, GHB

61
New cards

Hallucinogens / dissociatives

Alter perception, mood, cognition

LSD, psilocybin, PCP, ketamine

62
New cards

Cannabinoids

Euphoria and altered perception
Marijuana, hashish, synthetic cannabinoids

63
New cards

NPS

Mimic or evade controlled drugs

Cathinones, nitazenes, designer benzos

64
New cards

The analytical workflow

Receive & characterize → Analyze → Report & testify

Document and weigh first; sample representatively. Run presumptive tests, then confirm identity with at least two uncorrelated techniques. The deliverable is a defensiblereport and expert testimony, with chain of custody intact.

65
New cards

category a

Structural

MS (GC-MS, LC-MS), FTIR, Raman, NMR

66
New cards

category b

Moderate

TLC, GC, LC, ion mobility, melting point

67
New cards

category c

Screening

Color tests, immunoassay, UV/fluorescence

68
New cards

SWGDRUG rule

with a Category-A technique, add at least one more; without one, use ≥3 validated methods, two of them uncorrelated Category B. No single weak test is specific — presumptive narrows, confirmation identifies.

69
New cards

Marquis

Formaldehyde / H₂SO₄

Opiates purple; amphetamines orange-brown; MDMA purple-black

70
New cards

Scott

Cobalt(II) thiocyanate

Cocaine blue

71
New cards

Simon's

Nitroprusside / acetaldehyde

Secondary amines (methamphetamine) blue

72
New cards

Duquenois–Levine

Vanillin/acetaldehyde, HCl, chloroform

Cannabis purple in chloroform layer

73
New cards

Mecke

Vanillin/acetaldehyde, HCl, chloroform

Heroin green to blue-green

74
New cards

Ehrlich

p-DMAB in acid

LSD and other indoles purple

75
New cards

Heroin

6-MAM (specific marker) → morphine

76
New cards

Cocaine

Benzoylecgonine; cocaethylene only with alcohol

77
New cards

Cannabis (THC)

THC-COOH in urine (past use); THC in blood (recent)

78
New cards

Methamphetamine

Amphetamine (active metabolite)

79
New cards

Codeine

Morphine (via CYP2D6 O-demethylation — a prodrug)

80
New cards

Fentanyl

Norfentanyl in urine

81
New cards

Toxicology path

screen (immunoassay) → confirm (LC-MS/MS or GC-MS) → interpret parent vs metabolite, timing, and matrix.

82
New cards

pKa = −log₁₀ Ka.

The smaller the pKa the stronger the acid; the higher the pKa the stronger the base. pKa lets you find the degree of ionization of a drug at a given pH.

83
New cards

At biological pH ≈ 7.4

the ionization state governs absorption and distribution. The non-ionized form is more lipid-soluble (more lipophilic) and crosses membranes more readily — the key to where a drug goes.

84
New cards

Lipophilicity

ability to dissolve in fats/non-polar solvents; non-ionized drug is more lipophilic and better distributed

85
New cards

Protein binding

albumin binds acidic drugs; α₁-acid glycoprotein binds basic drugs; only free drug is active.

86
New cards

Volume of distribution (Vd)

high Vd means the drug leaves plasma for tissues (imipramine 20–40 L/kg); low Vd stays in plasma (ethanol <1 L/kg).


87
New cards

Size & structure and storage depots

(fat, bone) further shape distribution.

88
New cards

Stimulants Mechanism

raise dopamine, norepinephrine, and serotonin signaling; cocaine blocks reuptake, amphetamines and cathinones force release.

89
New cards

Forensic Stimulants

cocaineScott test (cocaine blue), Simon's (methamphetamine), benzoylecgonine and cocaethylene markers

90
New cards

Opioids — the poppy and the receptors

Opioids bind μ, δ, and κ receptors in the CNS and periphery.

The μ receptor drives the key effects: μ₁ = analgesia; μ₂ = respiratory and cardiovascular depression, sedation, euphoria, GI slowing, urinary retention — no μ₁-selective opioid exists. Opioids were ranked the most addictive drug class.

91
New cards

Opioids Signs

pinpoint pupils (miosis),

92
New cards

Morphine

Natural

Pure μ agonist; metabolites M3G, M6G

93
New cards

Codeine

Natural

Prodrug → morphine (CYP2D6); 7–10% are poor converters


94
New cards

Heroin

Semi-synthetic

Diacetylmorphine → 6-MAM → morphine

95
New cards

Oxycodone / hydrocodone

Semi-synthetic

Prescription; often counterfeited

96
New cards

Fentanyl

Synthetic

μ agonist; 50–100× morphine; no metabolites

97
New cards

Methadone

Synthetic

Long-acting; neuropathic pain; no metabolites


98
New cards

Tramadol

Atypical

Opioid + noradrenaline/serotonin; active M1


99
New cards

Fentanyl and its analogues — potency

Fentanyl is a synthetic piperidine μ agonist, 50–100× morphine, structurally like pethidine. 'Fentanyl' is a family — changing substituents on the core creates analogues with different potency and duration

100
New cards

Naloxone (Narcan)

pure opioid antagonist that displaces opioids from receptors, acting 30–60 min — it may wear off before a long-acting opioid, and does not work on non-opioid overdose.